{
    "title": "Vascular events in patients with head and neck cancer: A systematic review and meta-analysis.",
    "doc_id": "38334324",
    "writer": "Monaghan NP",
    "year": "2024",
    "summary": "OBJECTIVE: To assess the incidence of vascular events in patients with head and neck cancer. REVIEW METHODS: Primary studies identified through April 2023. Meta-analysis was performed. ...CONCLUSIONS: Vascular events occur in 4%-5% of patients with head and â€¦",
    "abstract": "Objective:\n        \n      \n      To assess the incidence of vascular events in patients with head and neck cancer.\n    \n\n\n          Review methods:\n        \n      \n      Primary studies identified through April 2023. Meta-analysis was performed.\n    \n\n\n          Results:\n        \n      \n      There were 146 studies included in the systematic review. Rates of events were collected in the overall group, those with chemoprophylaxis, and those that underwent surgery, radiation, or chemotherapy. Of 1 184 160 patients, 4.3% had a vascular event. Radiation therapy had highest risk of overall events and stroke when compared to surgery and chemotherapy. Chemotherapy had a higher risk of stroke and overall events when compared to surgery.\n    \n\n\n          Conclusions:\n        \n      \n      Vascular events occur in 4%-5% of patients with head and neck cancer. Our data does not support the use of routine anticoagulation. Patients undergoing radiation therapy had the highest frequency of events.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/38334324/"
}